Clinical Trial Update: A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

View source ↗

Summary

Real-world study results in adults with severe eosinophilic asthma treated with benralizumab (Fasenra) has been completed, focusing on clinical and patient-cent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Eosinophilic Asthma | Status: COMPLETED